Comparative effects of SGLT2 inhibitors and GLP-1 receptor agonists on osteoarthritis risk in patients with type 2 diabetes mellitus: A multi-institutional cohort study
Wen-Yu Jao, Chih‐Cheng Lai, Chi-Sheng Chien, Wei-Ting Lin · 2026
Read Comparative effects of SGLT2 inhibitors and GLP-1 receptor agonists on osteoarthritis risk in patients with type 2 diabetes mellitus: A multi-institutional cohort study by Wen-Yu Jao, Chih‐Cheng Lai, Chi-Sheng Chien, Wei-Ting Lin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353956.txt.
Description
Wen-Yu Jao and three colleagues compare two modern diabetes drug families for an unexpected side benefit, in this 2026 PLOS ONE database study. Both drug types control blood sugar and calm inflammation, which made researchers wonder whether they also protect joints. Using a huge multi-hospital record system, the team matched over four hundred and fifty thousand new users of one family against the same number starting the other.
Users of the first family, the SGLT2 blockers, developed osteoarthritis less often over five years than users of the GLP-1 medicines, especially in the knee. They also needed fewer major joint injections, though joint replacement rates matched. The authors call for trials to test whether the difference is real.
Catalog record
| CREATOR | Wen-Yu Jao, Chih‐Cheng Lai, Chi-Sheng Chien, Wei-Ting Lin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28852 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |